|
|
Volumn 493, Issue 7430, 2013, Pages 14-16
|
|
Infectious disease: TB's revenge
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIKACIN;
ANTIRETROVIRUS AGENT;
BCG VACCINE;
CAPREOMYCIN;
ISONIAZID;
KANAMYCIN;
MOXIFLOXACIN;
QUINOLONE DERIVATIVE;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
CLIMATE CHANGE;
COST-BENEFIT ANALYSIS;
DISEASE PREVALENCE;
DISEASE TRANSMISSION;
DISEASE TREATMENT;
HEALTH RISK;
INFECTIOUS DISEASE;
PUBLIC HEALTH;
ARTICLE;
BACTERIAL STRAIN;
DRUG RESISTANT TUBERCULOSIS;
EXTENSIVELY DRUG RESISTANT TUBERCULOSIS;
HEALTH CARE SYSTEM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MIXED INFECTION;
MULTIDRUG RESISTANT TUBERCULOSIS;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
PRIORITY JOURNAL;
TREATMENT RESPONSE;
TUBERCULOSIS;
TUBERCULOSIS CONTROL;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS;
HIV INFECTIONS;
HUMANS;
TUBERCULOSIS;
TUBERCULOSIS VACCINES;
WORLD HEALTH;
|
|
EID: 84871725540
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/493014a Document Type: Article |
|
Times cited : (43)
|
|
References (3)
|
